Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present TrovaGene, Inc. (NASDAQ: TROV).

Full DD Report for TROV

You must become a subscriber to view this report.


Recent News from (NASDAQ: TROV)

Guardant Health Begins U.S. IPO Effort
Quick Take Guardant Health ( GH ) intends to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm provides genomic cancer testing services from a single blood draw. GH is growing at an accelerating rate, has ample resources and co...
Source: SeekingAlpha
Date: September, 11 2018 12:30
Guardant Health on deck for IPO
Redwood City, CA-based Guardant Health ( GH ) has filed a prospectus for a $100M IPO. More news on: Guardant Health, TrovaGene, Inc., Roche Holding Ltd ADR, Healthcare stocks news, IPOs, Read more ...
Source: SeekingAlpha
Date: September, 06 2018 10:55
Trovagene Announces Predictive Clinical Biomarker Approach to Identify Acute Myeloid Leukemia (AML) Patients Most Likely to Respond to Onvansertib
SAN DIEGO , Sept. 5, 2018 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs for the treatment of leukemias, lymphomas and solid tumor cancers, today announced it has developed a me...
Source: PR Newswire
Date: September, 05 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-140.650.63040.650.6002260,099
2018-12-130.6820.6350.690.616408,430
2018-12-120.690.68030.69880.6601134,225
2018-12-110.690.69010.70720.68137,530
2018-12-100.700.68050.730.6802396,777

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1432,75781,99839.9485Short
2018-12-1346,61679,80058.4160Short
2018-12-1215,48133,46846.2561Short
2018-12-1145,45358,88777.1868Short
2018-12-1059,65488,40567.4781Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TROV.


About TrovaGene, Inc. (NASDAQ: TROV)

Logo for TrovaGene, Inc. (NASDAQ: TROV)

Not available

 

Contact Information

 

 

Current Management

  • Chuck W. Hunter / CEO
  • Andreas Braun / Acting President
  • Richard S. Kay / CFO
  • Gary Anthony / Vice President, Controller
  • Gianluigi Longinotti Buitoni / Executive Chairman
  • Kira Sheinerman /

Current Share Structure

  • Market Cap: $15,359,607 - 05/18/2018
  • Issue and Outstanding: 55,290,162 - 02/12/2018

 


Recent Filings from (NASDAQ: TROV)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 05 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: September, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 17 2018

 

 


Daily Technical Chart for (NASDAQ: TROV)

Daily Technical Chart for (NASDAQ: TROV)


Stay tuned for daily updates and more on (NASDAQ: TROV)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: TROV)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TROV is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TROV and does not buy, sell, or trade any shares of TROV. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/